search
Back to results

SWISS_EVIDENCE - Compartment Compressibility Monitoring Using CPM#1

Primary Purpose

Compartment Syndromes

Status
Completed
Phase
Not Applicable
Locations
Switzerland
Study Type
Interventional
Intervention
Measurement of compartment compressibility
Sponsored by
Compremium AG
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional diagnostic trial for Compartment Syndromes

Eligibility Criteria

18 Years - 84 Years (Adult, Older Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  • Healthy volunteers
  • Male and female
  • Age between 18 and 84

Exclusion Criteria:

  • Previous surgery to or fracture of the lower leg
  • Peripheral arterial or venous disease
  • History of compartment syndrome
  • Limb anomalies
  • General muscle disorder
  • Participants under the influence of excessive alcohol, consumption of narcotics or benzodiazepines prior to procedure
  • Participants under the effect of analgesic (< 12 hours)

Sites / Locations

  • Universitätsklinik für Orthopädische Chirurgie und Traumatologie Inselspital

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

CPM#1

Arm Description

Compartment compressibility ratio measurement using the CPM#1 device

Outcomes

Primary Outcome Measures

Inter-operator reproducibility with 3 raters
Inter-operator reproducibility will be assessed using intra-class correlation coefficients (two-way random effects, single rater, absolute agreement). Three independent raters will conduct one measurement on each of both legs of 21 volunteers.

Secondary Outcome Measures

Intra-operator reproducibility
Intra-operator reproducibility will be assessed using intra-class correlation coefficients (two-way mixed effects, single measurement, absolute agreement). One of the three independent raters will conduct two measurements on 42 legs (21 volunteers).
Participant's reported pain: baseline
Participant's reported pain will be assessed using a 0-100mm Visual Analogue Scale (VAS) at specific time points.
Participant's reported pain: at highest externally applied pressure
Participant's reported pain will be assessed using a 0-100mm Visual Analogue Scale (VAS) at specific time points.
Participant's reported pain: after the procedure
Participant's reported pain will be assessed using a 0-100mm Visual Analogue Scale (VAS) at specific time points.

Full Information

First Posted
April 25, 2022
Last Updated
May 19, 2022
Sponsor
Compremium AG
search

1. Study Identification

Unique Protocol Identification Number
NCT05367921
Brief Title
SWISS_EVIDENCE - Compartment Compressibility Monitoring Using CPM#1
Official Title
Clinical Validation of CPM#1 Compression Ratio Measurement on Healthy Volunteers
Study Type
Interventional

2. Study Status

Record Verification Date
May 2022
Overall Recruitment Status
Completed
Study Start Date
May 4, 2022 (Actual)
Primary Completion Date
May 17, 2022 (Actual)
Study Completion Date
May 17, 2022 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Compremium AG

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
Compartment syndrome is a very serious musculoskeletal disorder, which can lead to potentially devastating consequences, such as limb amputation and life-threatening conditions. It is a well described medical condition considered to be an orthopaedic emergency affecting all ages. Even though compartment syndrome is a well described medical condition, the appropriate treatment (i.e., fasciotomy to release tissue pressure) is invasive and involves its own risks. Furthermore, and of most critical importance is the timing for the intervention of a fasciotomy. The concerned limb may already have had severe, sometimes even irreversible, tissue damage due to high intra-compartmental pressure within 6 to 10 hours. The standard diagnostic method for compartment syndrome is an invasive intra-compartmental pressure measurement via insertion of a pressure monitoring device into the muscle compartment. Commercially available intra compartmental pressure monitors have a highly variable intra-observer reproducibility and user errors are common. Compared to the invasive modalities, the Compremium Compartmental Compressibility Monitoring System (CPM#1) shows promising advantages for the clinical application. Not only is the technology used for the CPM#1 device safe and non-invasive for the patient with minimal training required for the healthcare professionals, but it has also demonstrated high intra- and inter-observer reproducibility (as per bench tests and clinical settings with prototypes, to be confirmed in clinical studies like this one). The use of the CPM#1 device therefore facilitates the measurements, as it is based on pre-existing ultrasound methods and avoids any further risks to the patients compared to invasive compartmental pressure diagnosis methods.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Compartment Syndromes

7. Study Design

Primary Purpose
Diagnostic
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Masking Description
Investigators will be blinded to the measurement results.
Allocation
N/A
Enrollment
21 (Actual)

8. Arms, Groups, and Interventions

Arm Title
CPM#1
Arm Type
Experimental
Arm Description
Compartment compressibility ratio measurement using the CPM#1 device
Intervention Type
Device
Intervention Name(s)
Measurement of compartment compressibility
Intervention Description
Application of the CPM#1 device for compartment compressibility ratio measurement - 4 measurements on both legs of each healthy volunteer will be performed
Primary Outcome Measure Information:
Title
Inter-operator reproducibility with 3 raters
Description
Inter-operator reproducibility will be assessed using intra-class correlation coefficients (two-way random effects, single rater, absolute agreement). Three independent raters will conduct one measurement on each of both legs of 21 volunteers.
Time Frame
During the procedure which should last about 10 min/patient
Secondary Outcome Measure Information:
Title
Intra-operator reproducibility
Description
Intra-operator reproducibility will be assessed using intra-class correlation coefficients (two-way mixed effects, single measurement, absolute agreement). One of the three independent raters will conduct two measurements on 42 legs (21 volunteers).
Time Frame
During the procedure which should last about 10 min/patient
Title
Participant's reported pain: baseline
Description
Participant's reported pain will be assessed using a 0-100mm Visual Analogue Scale (VAS) at specific time points.
Time Frame
Before (5 min before procedure).
Title
Participant's reported pain: at highest externally applied pressure
Description
Participant's reported pain will be assessed using a 0-100mm Visual Analogue Scale (VAS) at specific time points.
Time Frame
During the procedure (the procedure will last about 10 min/patient)
Title
Participant's reported pain: after the procedure
Description
Participant's reported pain will be assessed using a 0-100mm Visual Analogue Scale (VAS) at specific time points.
Time Frame
Immediately after procedure (no follow up is planned)
Other Pre-specified Outcome Measures:
Title
Assessment of adverse events
Description
Safety of the procedure will be assessed by documenting adverse events (description of the adverse events, number of participants).
Time Frame
During the procedure which should last about 10 min/patient
Title
Assessment of device deficiencies
Description
Safety of the procedure will be assessed by documenting device deficiencies (description)
Time Frame
During the procedure which should last about 10 min/patient
Title
New risk identification
Description
Practitioner will be asked to identify risk due to the application of the device in patient care.
Time Frame
Within 12 hours after procedure (no follow up is planned)

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
84 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Healthy volunteers Male and female Age between 18 and 84 Exclusion Criteria: Previous surgery to or fracture of the lower leg Peripheral arterial or venous disease History of compartment syndrome Limb anomalies General muscle disorder Participants under the influence of excessive alcohol, consumption of narcotics or benzodiazepines prior to procedure Participants under the effect of analgesic (< 12 hours)
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Helen Anwander, Dr. med.
Organizational Affiliation
Department für Orthopädie und Traumatologie, Inselspital Bern
Official's Role
Principal Investigator
Facility Information:
Facility Name
Universitätsklinik für Orthopädische Chirurgie und Traumatologie Inselspital
City
Bern
ZIP/Postal Code
3010
Country
Switzerland

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

SWISS_EVIDENCE - Compartment Compressibility Monitoring Using CPM#1

We'll reach out to this number within 24 hrs